Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

1.

Integrating multiple aspects of mitochondrial dynamics in neurons: age-related differences and dynamic changes in a chronic rotenone model.

Arnold B, Cassady SJ, VanLaar VS, Berman SB.

Neurobiol Dis. 2011 Jan;41(1):189-200. doi: 10.1016/j.nbd.2010.09.006. Epub 2010 Sep 17.

PMID:
20850532
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson's disease.

Van Laar VS, Berman SB.

Neurobiol Dis. 2013 Mar;51:43-55. doi: 10.1016/j.nbd.2012.05.015. Epub 2012 Jun 2. Review.

PMID:
22668779
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Mitochondrial dynamics in Parkinson's disease.

Van Laar VS, Berman SB.

Exp Neurol. 2009 Aug;218(2):247-56. doi: 10.1016/j.expneurol.2009.03.019. Epub 2009 Mar 28. Review.

PMID:
19332061
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.

Takeuchi H, Yanagida T, Inden M, Takata K, Kitamura Y, Yamakawa K, Sawada H, Izumi Y, Yamamoto N, Kihara T, Uemura K, Inoue H, Taniguchi T, Akaike A, Takahashi R, Shimohama S.

J Neurosci Res. 2009 Feb;87(2):576-85. doi: 10.1002/jnr.21869.

PMID:
18803299
[PubMed - indexed for MEDLINE]
5.

An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.

Sherer TB, Betarbet R, Stout AK, Lund S, Baptista M, Panov AV, Cookson MR, Greenamyre JT.

J Neurosci. 2002 Aug 15;22(16):7006-15.

PMID:
12177198
[PubMed - indexed for MEDLINE]
Free Article
6.

Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.

Verma R, Nehru B.

Neurochem Int. 2009 Nov;55(6):369-75. doi: 10.1016/j.neuint.2009.04.001. Epub 2009 Apr 16.

PMID:
19375462
[PubMed - indexed for MEDLINE]
7.

Pretreatment with near-infrared light via light-emitting diode provides added benefit against rotenone- and MPP+-induced neurotoxicity.

Ying R, Liang HL, Whelan HT, Eells JT, Wong-Riley MT.

Brain Res. 2008 Dec 3;1243:167-73. doi: 10.1016/j.brainres.2008.09.057. Epub 2008 Sep 30.

PMID:
18848925
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline.

Casarejos MJ, Menéndez J, Solano RM, Rodríguez-Navarro JA, García de Yébenes J, Mena MA.

J Neurochem. 2006 May;97(4):934-46. Epub 2006 Mar 29.

PMID:
16573651
[PubMed - indexed for MEDLINE]
9.

Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.

Perfeito R, Cunha-Oliveira T, Rego AC.

Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3. Review.

PMID:
23743292
[PubMed - indexed for MEDLINE]
10.

Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.

Sherer TB, Kim JH, Betarbet R, Greenamyre JT.

Exp Neurol. 2003 Jan;179(1):9-16.

PMID:
12504863
[PubMed - indexed for MEDLINE]
11.

A highly reproducible rotenone model of Parkinson's disease.

Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, Greenamyre JT.

Neurobiol Dis. 2009 May;34(2):279-90.

PMID:
19385059
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Mitochondrial complex inhibitors preferentially damage substantia nigra dopamine neurons in rat brain slices.

Bywood PT, Johnson SM.

Exp Neurol. 2003 Jan;179(1):47-59.

PMID:
12504867
[PubMed - indexed for MEDLINE]
13.

Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases.

Chen H, Chan DC.

Hum Mol Genet. 2009 Oct 15;18(R2):R169-76. doi: 10.1093/hmg/ddp326. Review.

PMID:
19808793
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

p38(MAPK)/p53-Mediated Bax induction contributes to neurons degeneration in rotenone-induced cellular and rat models of Parkinson's disease.

Wu F, Wang Z, Gu JH, Ge JB, Liang ZQ, Qin ZH.

Neurochem Int. 2013 Sep;63(3):133-40. doi: 10.1016/j.neuint.2013.05.006. Epub 2013 May 25.

PMID:
23714208
[PubMed - indexed for MEDLINE]
15.

Identification of novel proteins affected by rotenone in mitochondria of dopaminergic cells.

Jin J, Davis J, Zhu D, Kashima DT, Leroueil M, Pan C, Montine KS, Zhang J.

BMC Neurosci. 2007 Aug 16;8:67.

PMID:
17705834
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models.

Xiong N, Long X, Xiong J, Jia M, Chen C, Huang J, Ghoorah D, Kong X, Lin Z, Wang T.

Crit Rev Toxicol. 2012 Aug;42(7):613-32. doi: 10.3109/10408444.2012.680431. Epub 2012 May 11. Review.

PMID:
22574684
[PubMed - indexed for MEDLINE]
17.

Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.

Testa CM, Sherer TB, Greenamyre JT.

Brain Res Mol Brain Res. 2005 Mar 24;134(1):109-18. Epub 2005 Jan 6.

PMID:
15790535
[PubMed - indexed for MEDLINE]
18.

Mitochondrial dynamics and neuronal fate in Parkinson's disease.

Santos D, Cardoso SM.

Mitochondrion. 2012 Jul;12(4):428-37. doi: 10.1016/j.mito.2012.05.002. Epub 2012 May 17. Review.

PMID:
22609323
[PubMed - indexed for MEDLINE]
19.

L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.

Saravanan KS, Sindhu KM, Senthilkumar KS, Mohanakumar KP.

Neurochem Int. 2006 Jul;49(1):28-40. Epub 2006 Feb 21.

PMID:
16490285
[PubMed - indexed for MEDLINE]
20.

DJ-1 protects dopaminergic neurons against rotenone-induced apoptosis by enhancing ERK-dependent mitophagy.

Gao H, Yang W, Qi Z, Lu L, Duan C, Zhao C, Yang H.

J Mol Biol. 2012 Oct 19;423(2):232-48. doi: 10.1016/j.jmb.2012.06.034. Epub 2012 Aug 14.

PMID:
22898350
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk